thisdrug what a medicine's name tells you

WHO naming stem · suffix · 20 listed names

-milast

Phosphodiesterase-4 (PDE4) inhibitors

WHO's definition, quoted as written in the 2024 stem book
Names only. This page is about -milast as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -milast. So the letters milast sit at the end of the name (…milast).

All 20 names WHO lists under -milast

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

  1. apremilast
  2. catramilast
  3. cilomilast
  4. difamilast
  5. dovramilast
  6. elbimilast
  7. indimilast
  8. lavamilast
  9. lirimilast
  10. lotamilast
  11. mufemilast
  12. oglemilast
  13. orismilast
  14. piclamilast
  15. revamilast
  16. roflumilast
  17. tanimilast
  18. tetomilast
  19. tofimilast
  20. zatolmilast

Decode another name

Decoded

apremilast

Listed INNCarries 2 WHO stems, most specific first: -milast …

  • -milastend of the nameWHO lists it hereWHO definition: Phosphodiesterase-4 (PDE4) inhibitors
  • -astend of the nameWHO lists it hereWHO definition: anti-allergic or anti-inflammatory, not acting as anti-histaminics

“apremilast” is an INN that WHO lists under -milast, -ast in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -milast (Part II B) and the 20 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.